Article

Decreased GABA(B) Receptors in the Cingulate Cortex and Fusiform Gyrus in Autism

Department of Anatomy and Neurobiology, Laboratory of Autism Neuroscience Research, Boston University School of Medicine, Boston, MA 02118, USA.
Journal of Neurochemistry (Impact Factor: 4.28). 09/2010; 114(5):1414-23. DOI: 10.1111/j.1471-4159.2010.06858.x
Source: PubMed

ABSTRACT

J. Neurochem. (2010) 114, 1414–1423.
Autism is a behaviorally defined neurodevelopmental disorder and among its symptoms are disturbances in face and emotional processing. Emerging evidence demonstrates abnormalities in the GABAergic (gamma-aminobutyric acid) system in autism, which likely contributes to these deficits. GABAB receptors play an important role in modulating synapses and maintaining the balance of excitation-inhibition in the brain. The density of GABAB receptors in subjects with autism and matched controls was quantified in the anterior and posterior cingulate cortex, important for socio-emotional and cognitive processing, and the fusiform gyrus, important for identification of faces and facial expressions. Significant reductions in GABAB receptor density were demonstrated in all three regions examined suggesting that alterations in this key inhibitory receptor subtype may contribute to the functional deficits in individuals with autism. Interestingly, the presence of seizure in a subset of autism cases did not have a significant effect on the density of GABAB receptors in any of the three regions.

Download full-text

Full-text

Available from: Gene J Blatt
  • Source
    • "Six control ROIs (three anatomical and three functional) were additionally selected based on structures and functions that have been implicated in ASC, but not associated with atypical lateralization. Anatomical ROIs comprised: the anterior cingulate cortex (ACC) [Amaral et al., 2008; Dichter et al., 2009; Oblak et al., 2010; Thakkar et al., 2008], the caudate [Amaral et al., 2008; Langen et al., 2007; Sears et al., 1999], and the fusiform gyrus (FFG) [Amaral et al., 2008; Kwon et al., 2004; Oblak et al., 2010; van Kooten et al., 2008]. Functional ROIs were based on the neurosynth search terms " emotion regulation " (161 studies; k 5 404 voxels) [Mazefsky et al., 2013; Samson et al., 2012], " mentalizing " (124 studies; k 5 1,866 voxels) [Baron-Cohen, 1995; Frith, 2001], and " sensory " (949 studies; k 5 725 voxels) [Leekam et al., 2007; Marco et al., 2011; Tomchek and Dunn, 2007]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In humans, both language and fine motor skills are associated with left-hemisphere specialization, whereas visuospatial skills are associated with right-hemisphere specialization. Individuals with autism spectrum conditions (ASC) show a profile of deficits and strengths that involves these lateralized cognitive functions. Here we test the hypothesis that regions implicated in these functions are atypically rightward lateralized in individuals with ASC and, that such atypicality is associated with functional performance. Participants included 67 male, right-handed adults with ASC and 69 age- and IQ-matched neurotypical males. We assessed group differences in structural asymmetries in cortical regions of interest with voxel-based analysis of grey matter volumes, followed by correlational analyses with measures of language, motor and visuospatial skills. We found stronger rightward lateralization within the inferior parietal lobule and reduced leftward lateralization extending along the auditory cortex comprising the planum temporale, Heschl's gyrus, posterior supramarginal gyrus, and parietal operculum, which was more pronounced in ASC individuals with delayed language onset compared to those without. Planned correlational analyses showed that for individuals with ASC, reduced leftward asymmetry in the auditory region was associated with more childhood social reciprocity difficulties. We conclude that atypical cerebral structural asymmetry is a potential candidate neurophenotype of ASC. Hum Brain Mapp, 2015. © 2015 Wiley Periodicals, Inc.
    Full-text · Article · Oct 2015 · Human Brain Mapping
    • "Reduced d 3H-muscimol-labeled GABA A receptor binding sites have also been observed in A the posterior cingulate cortex and fusiform gyrus (Oblak et al. 2011 ). Finally, 3 H- CGP54626-labeled GABA B receptor binding sites have also been observed to be reduced in the anterior and posterior cingulate cortex and fusiform gyrus of subjects with autism (Oblak et al. 2010 ). Consistent with the results of binding assays, GABA A and GABA A B receptor subunit proteins have been shown to be reduced in brains of subjects with autism (Fatemi et al. 2009a , b , 2010a , 2014 ). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autism is a heterogeneous neurodevelopmental disorder. The etiology of autism remains unknown although both genetic and environmental factors are likely to be involved. These factors disrupt the course of normal brain development from the cellular to the gross anatomical levels. The Reelin, gamma-aminobutyric acid (GABA), and fragile X mental retardation protein (FMRP)-metabotropic glutamate receptor 5 (mGluR5) signaling systems play important roles during the development of the nervous system. Disruption of these pathways is likely to lead to altered synaptic transmission and, ultimately, the cognitive and behavioral deficits associated with autism. This chapter describes each of these signaling systems and summarizes the current evidence that link them to autism. Therapies that target molecules in these signaling systems may provide new means of treating the core symptoms of autism.
    No preview · Article · Jan 2015
    • "Additionally reduced 3 H-muscimol-labeled GABA A receptor binding sites have been observed in the posterior cingulate cortex and fusiform gyrus of subjects with autism (Oblak et al., 2011). Finally, reduced GABA B receptor binding sites, as measured using 3 H-CGP54626-labeling, have also been identified in the posterior cingulate cortex and fusiform gyrus of subjects with autism (Oblak et al., 2010). Taken together, these studies have demonstrated widespread changes in GABA binding sites in the brains of subjects with schizophrenia and autism. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. GABAergic receptor abnormalities have been documented in several major psychiatric disorders including schizophrenia, mood disorders, and autism. Abnormal expression of mRNA and protein for multiple GABA receptors has also been observed in multiple brain regions leading to alterations in the balance between excitatory/inhibitory signaling in the brain with potential profound consequences for normal cognition and maintenance of mood and perception. Altered expression of GABAA receptor subunits has been documented in fragile X mental retardation 1 (FMR1) knockout mice, suggesting that loss of its protein product, fragile X mental retardation protein (FMRP), impacts GABAA subunit expression. Recent postmortem studies from our laboratory have shown reduced expression of FMRP in the brains of subjects with schizophrenia, bipolar disorder, major depression, and autism. FMRP acts as a translational repressor and, under normal conditions, inhibits metabotropic glutamate receptor 5 (mGluR5)-mediated signaling. In fragile X syndrome (FXS), the absence of FMRP is hypothesized to lead to unregulated mGluR5 signaling, ultimately resulting in the behavioral and intellectual impairments associated with this disorder. Our laboratory has identified changes in mGluR5 expression in autism, schizophrenia, and mood disorders. In the current review article, we discuss our postmortem data on GABA receptors, FMRP, and mGluR5 levels and compare our results with other laboratories. Finally, we discuss the interactions between these molecules and the potential for new therapeutic interventions that target these interconnected signaling systems. Copyright © 2014 Elsevier B.V. All rights reserved.
    No preview · Article · Nov 2014 · Schizophrenia Research
Show more